Lv3
290 积分 2025-09-25 加入
Antibody-drug conjugate design and mechanisms of action for cancer treatment: state of the art and beyond
1天前
已完结
Enabling Access to sp 3 ‐Enriched Targeted Protein Degraders via Redox‐Neutral Radical Cross‐Coupling
24天前
已完结
Harnessing FBXO31 with terminal amide-functionalized molecules for targeted protein degradation
30天前
已完结
Further Insight into the DNA Recognition Mechanism of Trabectedin from the Differential Affinity of Its Demethylated Analogue Ecteinascidin ET729 for the Triplet DNA Binding Site CGA
1个月前
已完结
The Role of Natural Product Chemistry in Drug Discovery: Two Decades of Progress and Perspectives
1个月前
已完结
Discovery of Novel Alkynylbenzene Scaffold-Based PTPN2-Selective Degrader PD-305 with Exceptional Potency and In Vivo Efficacy
1个月前
已完结
Trabectedin Mechanism of Action: What’s New?
1个月前
已关闭
Azole derivatives as histamine H3 receptor antagonists, Part I: Thiazol-2-yl ethers
1个月前
已关闭
Azole derivatives as histamine H3 receptor antagonists, Part I: Thiazol-2-yl ethers
1个月前
已完结
Discovery of cycloalkyl-fused N-thiazol-2-yl-benzamides as tissue non-specific glucokinase activators: Design, synthesis, and biological evaluation
1个月前
已完结
皖公网安备34019202002308
